Graft versus host disease (GvHD) is a generalised immune system reaction following allogeneic hematopoietic stem cell transplantation (AHSCT) in patients with acquired and congenital hematopoietic …

The need to improve efficiency and effectiveness of clinical trials has been well documented – and a new survey reveals that the life sciences industry …

Today, more than ever, pharmaceutical and biotech companies are under great pressure to run their business in a way that makes drug development processes more …

The use of biomarkers in drug discovery and development has exploded at an unprecedented rate since the turn of the century. With recent scientific and …

As financial pressures continue to bear down on the clinical research sector, it is vital that both sponsor companies and the CROs that conduct their …